Publications by authors named "Joyce Lubbers"

Background: Glioblastomas manipulate the immune system both locally and systemically, yet, glioblastoma-associated changes in peripheral blood immune composition are poorly studied. Age and dexamethasone administration in glioblastoma patients have been hypothesized to limit the effectiveness of immunotherapy, but their effects remain unclear. We compared peripheral blood immune composition in patients with different types of brain tumor to determine the influence of age, dexamethasone treatment, and tumor volume.

View Article and Find Full Text PDF

Background: House dust mite extract-based allergen immunotherapy (AIT) to treat house dust mite allergy is substantially effective but still presents some safety and efficacy concerns that warrant improvement. Several major allergen-based approaches to increase safety and efficacy of AIT have been proposed. One of them is the use of the group 2 allergen, Der p 2.

View Article and Find Full Text PDF

Identification of human cancer-reactive CD8+ T cells is crucial for the stratification of patients for immunotherapy and determination of immune-therapeutic effects. To date, these T cells have been identified mainly based on cell surface expression of programmed cell death protein 1 (PD-1) or co-expression of CD103 and CD39. A small subset of CD103- CD39+ CD8+ T cells is also present in tumors, but little is known about these T cells.

View Article and Find Full Text PDF
Article Synopsis
  • The activation of STING is crucial for boosting anti-tumor immunity, and its dysfunction is linked to bad outcomes in various cancers.
  • In our study on cervical cancer, we found that higher levels of STING protein correlate with better survival rates in patients treated with either surgery or radio(chemo)therapy.
  • Additionally, the presence of CD103+ T cells, which are associated with a positive prognosis, enhances survival rates, especially in those receiving radio(chemo)therapy.
  • Combining STING protein levels and CD103+ T cell presence could help better predict outcomes for cervical cancer patients.
View Article and Find Full Text PDF

Unlabelled: Dendritic cells (DCs) are key in the initiation of the adaptive T cell responses to tailor adequate immunity that corresponds to the type of pathogen encountered. Oppositely, DCs control the resolution phase of inflammation and are able to induce tolerance after receiving anti-inflammatory cytokines or upon encounter of self-associated molecular patterns, such as α2-3 linked sialic acid (α2-3sia).

Objective: We here investigated whether α2-3sia, that bind immune inhibitory Siglec receptors, would alter signaling and reprogramming of LPS-stimulated human monocyte-derived DCs (moDCs).

View Article and Find Full Text PDF

DNA-sensing receptor Cyclic GMP-AMP Synthase (cGAS) and its downstream signaling effector STimulator of INterferon Genes (STING) have gained significant interest in the field of tumor immunology, as a dysfunctional cGAS-STING pathway is associated with poor prognosis and worse response to immunotherapy. However, studies so far have not taken into account the polymorphic nature of the STING-encoding STING1 gene. We hypothesized that the presence of allelic variance in STING1 would cause variation between individuals as to their susceptibility to cancer development, cancer progression, and potential response to (immuno)therapy.

View Article and Find Full Text PDF
Article Synopsis
  • Epithelial Ovarian Cancer (EOC) is a highly deadly form of cancer with few effective treatments, and while immunotherapy shows potential, it currently works well for only a limited number of patients.
  • Combining immunotherapy with standard chemotherapy drugs like carboplatin and paclitaxel could enhance effectiveness, as evidence suggests the immune response and cancer characteristics are influenced by the tissue type rather than chemotherapy exposure.
  • The immune environment in ovarian tumors shows distinct patterns, with certain markers linked to better survival outcomes, pointing to the need for strategies that could enhance immune responses post-chemotherapy by increasing MHC-I expression.
View Article and Find Full Text PDF

In this study we developed a liposome-based vaccine containing palmitoylated synthetic long peptides (SLP) and alpha galactosylceramide (αGC) to specifically target dendritic cells (DC) for activation of both innate (invariant natural killer T-cells [iNKT]) and adaptive (CD8 T-cells) players of the immune system. Combination of model tumor specific antigens (gp100/MART-1) formulated as a SLP and αGC in one liposome results in strong activation of CD8 and iNKT, as measured by IFNγ secretion. Moreover, addition of lipo-Lewis Y (Le) to the liposomes for C-type lectin targeting increased not only uptake by monocyte-derived dendritic cells (moDC), dermal dendritic cells and Langerhans cells but also enhanced gp100-specific CD8 T- and iNKT cell activation by human skin-emigrated antigen presenting cells in an explant model.

View Article and Find Full Text PDF
Article Synopsis
  • Many tumors show changes in glycosylation pathways, leading to increased tumor-associated glycan structures that correlate with metastasis and poor prognosis.
  • Antigen presenting cells recognize these altered glycans, like the Tn antigen, which triggers immune responses through the C-type lectin MGL on dendritic cells, promoting regulatory T cell activation.
  • Our study reveals that stimulation of dendritic cells with MGL glycan ligands results in reduced expression of genes related to important metabolic pathways, indicating a potential decrease in their glycolytic activity and enhancing our understanding of how tumor-associated glycans influence immunity.
View Article and Find Full Text PDF

The chemokine CXCL13 mediates recruitment of B cells to tumors and is essential for the formation of tertiary lymphoid structures (TLSs). TLSs are thought to support antitumor immunity and are associated with improved prognosis. However, it remains unknown whether TLSs are formed in response to the general inflammatory character of the tumor microenvironment, or rather, are induced by (neo)antigen-specific adaptive immunity.

View Article and Find Full Text PDF

One of the key features of the immune system is its extraordinary capacity to discriminate between self and non-self and to respond accordingly. Several molecular interactions allow the induction of acquired immune responses when a foreign antigen is recognized, while others regulate the resolution of inflammation, or the induction of tolerance to self-antigens. Post-translational signatures, such as glycans that are part of proteins (glycoproteins) and lipids (glycolipids) of host cells or pathogens, are increasingly appreciated as key molecules in regulating immunity vs.

View Article and Find Full Text PDF

Due to its unique immunological properties, the skin is an attractive target tissue for allergen-specific immunotherapy. In our current work, we combined a dendritic cell targeting approach with epicutaneous immunization using an ablative fractional laser to generate defined micropores in the upper layers of the skin. By coupling the major birch pollen allergen Bet v 1 to mannan from S.

View Article and Find Full Text PDF

Background: Multiple lymphocyte subsets like T and B cells have been connected to joint infiltration and inflammation in rheumatoid arthritis (RA). Identification of leucocyte subsets that are dysregulated in arthritis development could provide insight into the aetiology of RA. This study aimed to investigate the composition of the peripheral blood components, i.

View Article and Find Full Text PDF

Background: The type I interferon (IFN) signature in rheumatoid arthritis (RA) has shown clinical relevance in relation to disease onset and therapeutic response. Identification of the cell type(s) contributing to this IFN signature could provide insight into the signature's functional consequences. The aim of this study was to investigate the contribution of peripheral leukocyte subsets to the IFN signature in early arthritis.

View Article and Find Full Text PDF

Myeloid-derived suppressor cells (MDSCs) contribute to tumor-mediated immune escape and negatively correlate with overall survival of cancer patients. Nowadays, a variety of methods to target MDSCs are being investigated. Based on the intervention stage of MDSCs, namely development, expansion and activation, function and turnover, these methods can be divided into: (I) prevention or differentiation to mature cells, (II) blockade of MDSC expansion and activation, (III) inhibition of MDSC suppressive activity or (IV) depletion of intratumoral MDSCs.

View Article and Find Full Text PDF

Objectives: To validate the presence and demonstrate the clinical value of the type I interferon (IFN)-signature during arthritis development.

Method: In 115 seropositive arthralgia patients who were followed for the development of arthritis (Amsterdam Reade cohort), and 25 presymptomatic individuals who developed rheumatoid arthritis (RA) later, and 45 population-based controls (Northern Sweden cohort), the expression levels of 7 type I IFN response genes were determined with multiplex qPCR and an IFN-score was calculated. The diagnostic performance of the IFN-score was evaluated using Cox regression and Receiver Operating Characteristics (ROC)-curve analysis.

View Article and Find Full Text PDF